937046-96-3 ((2-氰基-1H-吡咯-1-基)氨基甲酸叔丁酯,N-(2-cyano-1H-pyrrol-1-yl)(tert-butoxy)formamide)

CAS号:
937046-96-3
中文名称:
(2-氰基-1H-吡咯-1-基)氨基甲酸叔丁酯
英文名称:
N-(2-cyano-1H-pyrrol-1-yl)(tert-butoxy)formamide
分子式:
C10H13N3O2
分子量:
207.229121923447

(2-氰基-1H-吡咯-1-基)氨基甲酸叔丁酯(937046-96-3)名称与标识符

名称

中文别名:
(2-氰基-1H-吡咯-1-基)氨基甲酸叔丁酯;2-氰基-1H-吡咯-1-氨基甲酸叔丁酯;
英文别名:
tert-Butyl (2-cyano-1H-pyrrol-1-yl)carbamate;Carbamic acid, N-(2-cyano-1H-pyrrol-1-yl)-, 1,1-dimethylethyl ester;tert-butyl 2-cyano-1H-pyrrol-1-ylcarbamate;tert-butyl N-(2-cyanopyrrol-1-yl)carbamate;1-N-Boc-Amino-2-cyanopyrrole;N-(2-cyano-1H-pyrrol-1-yl)(tert-butoxy)formamide;SXUSNFHKHIJDRN-UHFFFAOYSA-N;PB23986;FCH1629140;TZ000838;AB0027760;AX8224459;ST24025791;W9633;tert-Butyl (2-cyano-1H-pyrrol-1-yl);carbamate;2-Cyano-pyrrol-1-yl-car;1,1-Dimethylethyl N-(2-cyano-1H-pyrrol-1-yl)carbamate (ACI);NS00006411;MFCD12068393;AKOS015919803;SCHEMBL66516;DB-371829;CS-0037682;2-Cyano-pyrrol-1-yl-carbamic acid, tert-butyl ester;1-(Boc-amino)-2-cyanopyrrole;DTXSID00679391;1-(Boc-amino)-2-pyrrolecarbonitrile;EC 810-524-9;tert-Butyl(2-cyano-1H-pyrrol-1-yl)carbamate;EN300-120186;(2-Cyano-pyrrol-1-yl)-carbamic acid, tert-butyl ester;937046-96-3;AS-35837;SY020951;(2-CYANO-PYRROL-1-YL)-CARBAMIC ACID TERT-BUTYL ESTER;

标识符

MDL:
MFCD12068393
InChIKey:
SXUSNFHKHIJDRN-UHFFFAOYSA-N
Inchi:
1S/C10H13N3O2/c1-10(2,3)15-9(14)12-13-6-4-5-8(13)7-11/h4-6H,1-3H3,(H,12,14)
SMILES:
N#CC1N(NC(OC(C)(C)C)=O)C=CC=1

(2-氰基-1H-吡咯-1-基)氨基甲酸叔丁酯(937046-96-3)物化性质

实验特性

  • LogP : 1.91138
  • PSA : 67.05000
  • 颜色与性状 : White to Yellow Solid
  • 密度 : 1.12

计算特性

  • 精确分子量 : 207.10100
  • 氢键供体数量 : 1
  • 氢键受体数量 : 3
  • 可旋转化学键数量 : 3
  • 同位素质量 : 207.100776666g/mol
  • 重原子数量 : 15
  • 复杂度 : 287
  • 同位素原子数量 : 0
  • 确定原子立构中心数量 : 0
  • 不确定原子立构中心数量 : 0
  • 确定化学键立构中心数量 : 0
  • 不确定化学键立构中心数量 : 0
  • 共价键单元数量 : 1
  • 疏水参数计算参考值(XlogP) : 2.3
  • 拓扑分子极性表面积 : 67

(2-氰基-1H-吡咯-1-基)氨基甲酸叔丁酯(937046-96-3)安全信息

(2-氰基-1H-吡咯-1-基)氨基甲酸叔丁酯(937046-96-3)海关数据

海关编码:
2933990090
海关数据:

中国海关编码:

2933990090

概述:

2933990090. 其他仅含氮杂原子的杂环化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0%

申报要素:

品名, 成分含量, 用途, 乌洛托品请注明外观, 6-己内酰胺请注明外观, 签约日期

Summary:

2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0%

(2-氰基-1H-吡咯-1-基)氨基甲酸叔丁酯(937046-96-3)推荐厂家 更多厂家(24)

(2-氰基-1H-吡咯-1-基)氨基甲酸叔丁酯(937046-96-3)合成路线

合成路线:1 步
反应条件:
参考文献:
Discovery of Rogaratinib (BAY 1163877): a pan-FGFR Inhibitor
Collin, Marie-Pierre ; Lobell, Mario; Huebsch, Walter; Brohm, Dirk; Schirok, Hartmut; et al, ChemMedChem, 2018, 13(5), 437-445
合成路线:1 步
反应条件:
参考文献:
Preparing method and application of tricyclic compounds capable of inhibiting EGFR kinase mutant
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Green preparation of remdesivir intermediate
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Method for preparing 7-bromopyrrolo[2,1-f][1,2,4]triazin-4-amine as GS-441524 intermediate for treating feline infectious peritonitis (FIP)
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Synthesis of 7-bromopyrrolo[2,1-f][1,2,4]triazin-4-amine
Zheng, Jun; Cao, Guo-rui, Huaxue Shiji, 2020, 42(5), 608-611
合成路线:1 步
反应条件:
参考文献:
Preparation of the monohydrate of rogaratinib hydrochloride and solid states thereof
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of substituted 4-aminopyrrolotriazine derivatives useful for treating hyperproliferative disorders and diseases associated with angiogenesis
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of pyrrolo[2,1-f][1,2,4]triazin-4-ylamines as IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of multicyclic heterocycles as Janus kinase inhibitors for treating cancer or modifying an immune response
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Pyrrolopyridazines and pyrrolotriazines as janus kinase inhibitors and their preparation and use for the treatment of JAK-associated diseases
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of piperidine derivatives as immunosuppressant for the treatment of diseases associated with pathologic JAK3 activation
, World Intellectual Property Organization, , ,
合成路线:1 步
参考文献:
Facile and Scalable Methodology for the Pyrrolo[2,1-f][1,2,4]triazine of Remdesivir
Roy, Sarabindu; Yadaw, Ajay; Roy, Subho; Sirasani, Gopal; Gangu, Aravind; et al, Organic Process Research & Development, 2022, 26(1), 82-90
合成路线:1 步
反应条件:
参考文献:
N-heterocycle-containing derivative and its pharmaceutical application
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Green preparation of remdesivir intermediate 7-iodopyrrolo[2,1-F][1,2,4]triazine-4-amine
, China, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of CDK kinase inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
FGFR inhibitor and medical application thereof
, World Intellectual Property Organization, , ,
合成路线:1 步
反应条件:
参考文献:
Preparation of pyrrolotriazine derivatives as Btk inhibitors
, World Intellectual Property Organization, , ,
合成路线:1 步
参考文献:
Piperidine derivatives as jak3 inhibitors
, United States, , ,

(2-氰基-1H-吡咯-1-基)氨基甲酸叔丁酯(937046-96-3)参考资料

Beilstein:
N178333
PubChem CID: